Literature DB >> 7429606

Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes.

G F Webster, J J Leyden.   

Abstract

The size and production of polymorphonuclear leukocyte (PMN) chemotactic factors by Propionibacterium acnes has been studied. All eight strains of P. acnes which were tested liberated PMN chemotactic factors in their growth culture media. The factor(s) produced by one strain, 6919, were studied in greater depth. The PMN response was proportional to the dose of culture supernatant and chemotactic activity increased with the duration of P. acnes culture. The neutrophil migration towards culture supernatants was chemotactic, with a slight stimulation of random migration by 72-h supernatants. The size of the chemotactic molecules was studied through dialysis, ultrafiltration, and Sephadex G-25 chromatography of 72-h supernatants. Low-molecular-weight chemotactic factors were found to be predominant by each method of size determination.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429606     DOI: 10.1007/bf00915027

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  10 in total

1.  Inflammatory mediators in culture filtrates of Escherichia coli.

Authors:  T Yoshida; S Cohen; P E Bigazzi; T Kurasuji; A Amsden
Journal:  Am J Pathol       Date:  1975-11       Impact factor: 4.307

2.  Complement activation by Corynebacterium acnes.

Authors:  A Massey; J F Mowbray; W C Noble
Journal:  Br J Dermatol       Date:  1978-05       Impact factor: 9.302

3.  The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli.

Authors:  E Schiffmann; H V Showell; B A Corcoran; P A Ward; E Smith; E L Becker
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

4.  Dermal hypersensitivity of patients with acne vulgaris to Corynebacterium acnes.

Authors:  S M Puhvel; I K Hoffman; R M Reisner; T H Sternberg
Journal:  J Invest Dermatol       Date:  1967-08       Impact factor: 8.551

5.  Bacterial factors chemotactic for polymorphonuclear leukocytes.

Authors:  P A Ward; I H Lepow; L J Newman
Journal:  Am J Pathol       Date:  1968-04       Impact factor: 4.307

6.  Role of anaerobic coryneforms in specific and non-specific immunological reactions. II. Production of a chemotactic factor specific for macrophages.

Authors:  P C Wilkinson; G J O'Neill; K G Wapshaw
Journal:  Immunology       Date:  1973-06       Impact factor: 7.397

7.  Complement activation in acne vulgaris: in vitro studies with Propionibacterium acnes and Propionibacterium granulosum.

Authors:  G F Webster; J J Leyden; M E Norman; U R Nilsson
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

8.  Complement activation in acne vulgaris: consumption of complement by comedones.

Authors:  G F Webster; J J Leyden; U R Nilsson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

9.  The chemoattractant properties of comedonal components.

Authors:  S M Puhvel; M Sakamoto
Journal:  J Invest Dermatol       Date:  1978-11       Impact factor: 8.551

10.  Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients.

Authors:  G F Webster; J J Leyden; C C Tsai; P Baehni; W P McArthur
Journal:  J Invest Dermatol       Date:  1980-06       Impact factor: 8.551

  10 in total
  16 in total

1.  Leukocyte chemotactic properties of soluble horny contents in epidermal cysts.

Authors:  H Takematsu; T Terui; W Torinuki; H Tagami
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo.

Authors:  Sewon Kang; Soyun Cho; Jin Ho Chung; Craig Hammerberg; Gary J Fisher; John J Voorhees
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

3.  Tretinoin: A Review of Its Anti-inflammatory Properties in the Treatment of Acne.

Authors:  Nicholas Schmidt; Eugene H Gans
Journal:  J Clin Aesthet Dermatol       Date:  2011-11

4.  The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes.

Authors:  Darren Yang; Dissaya Pornpattananangkul; Teruaki Nakatsuji; Michael Chan; Dennis Carson; Chun-Ming Huang; Liangfang Zhang
Journal:  Biomaterials       Date:  2009-08-08       Impact factor: 12.479

5.  Susceptibility of Propionibacterium acnes to killing and degradation by human neutrophils and monocytes in vitro.

Authors:  G F Webster; J J Leyden; R A Musson; S D Douglas
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

6.  Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin.

Authors:  G F Webster; J J Leyden; K J McGinley; W P McArthur
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

7.  Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne.

Authors:  B R Vowels; S Yang; J J Leyden
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

8.  Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris.

Authors:  Teruaki Nakatsuji; Mandy C Kao; Jia-You Fang; Christos C Zouboulis; Liangfang Zhang; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2009-04-23       Impact factor: 8.551

Review 9.  Current concepts of the pathogenesis of acne: implications for drug treatment.

Authors:  Harald Gollnick
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Antibodies elicited by inactivated propionibacterium acnes-based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris.

Authors:  Teruaki Nakatsuji; Yu-Tsueng Liu; Cheng-Po Huang; Christos C Zoubouis; Richard L Gallo; Chun-Ming Huang
Journal:  J Invest Dermatol       Date:  2008-05-08       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.